Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefdinir vs Amoxicillin/Clavulanate in Acute Sinusitis QOL
NCT00147914Phase 4Completed
- Sponsor
- University of Chicago
- Start
- Feb 2005
- Primary completion
- Feb 2007
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised trial of cefdinir in acute bacterial sinusitis (ABS) (2 arms), sponsored by University of Chicago. Primary endpoints: Improvement in quality of life and SNOT 20 questionnaire. Started Feb 2005; status: completed.
02
Drugs
cefdinir
03
Conditions
acute bacterial sinusitis (ABS)
Beyond the preview
Go deeper on NCT00147914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147914.